Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ErgoSpine is a private U.S. medical device startup focused on motion-preserving spinal implants. The company has developed ErgoFlex, a proprietary total disc replacement technology intended as a non-fusion solution for lumbar disc disease, with the design described as adaptable to other regions of the spine including the cervical spine. Publicly available descriptions portray the lead product as a third-generation artificial disc that is reversible, easy to implant, and in limited production for testing rather than in broad commercial use. The company appears to operate as an early-stage spine technology developer rather than a drug-development biotech or pharmaceutical company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ErgoSpine.